2575 — Xuanzhu Biopharmaceutical Co Cashflow Statement
0.000.00%
Last trade - 00:00- HK$17.56bn
- HK$17.44bn
- CNY30.09m
Annual cashflow statement for Xuanzhu Biopharmaceutical Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2023 December 31st | 2024 December 31st | |
|---|---|---|
| Period Length: | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS |
| Standards: | IFRS | IFRS |
| Status: | Final | Final |
| Net Income/Starting Line | -301 | -556 |
| Depreciation | ||
| Amortisation | ||
| Non-Cash Items | 58.3 | 403 |
| Unusual Items | ||
| Other Non-Cash Items | ||
| Changes in Working Capital | 94.1 | -7.45 |
| Change in Accounts Receivable | ||
| Change in Inventories | ||
| Change in Prepaid Expenses | ||
| Change in Other Assets | ||
| Change in Accounts Payable | ||
| Change in Other Liabilities | ||
| Other Operating Cash Flow | ||
| Cash from Operating Activities | -116 | -127 |
| Capital Expenditures | -146 | -80.2 |
| Purchase of Fixed Assets | ||
| Purchase / Acquisition of Intangibles | ||
| Other Investing Cash Flow Items | 191 | 212 |
| Sale of Fixed Assets | ||
| Sale/Maturity of Investment | ||
| Purchase of Investments | ||
| Sale of Intangible Assets | ||
| Cash from Investing Activities | 44.7 | 132 |
| Financing Cash Flow Items | -2.33 | -7.16 |
| Other Financing Cash Flow | ||
| Net Issuance / Retirement of Debt | ||
| Cash from Financing Activities | -9.9 | -12.4 |
| Foreign Exchange Effects | ||
| Beginning Cash Balance | ||
| Ending Cash Balance | ||
| Net Change in Cash | -81.2 | -7.64 |